Literature DB >> 25486132

An entity evolving into a community: defining the common ancestor and evolutionary trajectory of chronic lymphocytic leukemia stereotyped subset #4.

Lesley-Ann Sutton1, Giorgos Papadopoulos2, Anastasia Hadzidimitriou1,3, Stavros Papadopoulos2, Efterpi Kostareli4, Richard Rosenquist1, Dimitrios Tzovaras2, Kostas Stamatopoulos1,3,5.   

Abstract

Patients with chronic lymphocytic leukemia (CLL) assigned to stereotyped subset #4 express highly homologous B-cell receptor immunoglobulin (BcR IG) sequences with intense intraclonal diversification (ID) in the context of ongoing somatic hypermutation (SHM). Their remarkable biological and clinical similarities strongly support derivation from a common ancestor. We here revisited ID in subset #4 CLL to reconstruct their evolutionary history as a community of related clones. To this end, using specialized bioinformatics tools we assessed both IGHV-IGHD-IGHJ rearrangements (n = 511) and IGKV-IGKJ rearrangements (n = 397) derived from eight subset #4 cases. Due to high sequence relatedness, a number of subclonal clusters from different cases lay very close to one another, forming a core from which clusters exhibiting greater variation stemmed. Minor subclones from individual cases were mutated to such an extent that they now resembled the sequences of another patient. Viewing the entire subset #4 data set as a single entity branching through diversification enabled inference of a common sequence representing the putative ancestral BcR IG expressed by their still elusive common progenitor. These results have implications for improved understanding of the ontogeny of CLL subset #4, as well as the design of studies concerning the antigenic specificity of the clonotypic BcR IGs.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25486132      PMCID: PMC4398667          DOI: 10.2119/molmed.2014.00140

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  36 in total

Review 1.  Anti-DNA antibodies: aspects of structure and pathogenicity.

Authors:  Y J Jang; B D Stollar
Journal:  Cell Mol Life Sci       Date:  2003-02       Impact factor: 9.261

2.  Structural basis for autoantibody recognition of phosphatidylserine-beta 2 glycoprotein I and apoptotic cells.

Authors:  B A Cocca; S N Seal; P D'Agnillo; Y M Mueller; P D Katsikis; J Rauch; M Weigert; M Z Radic
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

3.  Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin.

Authors:  Charles C Chu; Rosa Catera; Lu Zhang; Sebastien Didier; Briana M Agagnina; Rajendra N Damle; Matthew S Kaufman; Jonathan E Kolitz; Steven L Allen; Kanti R Rai; Nicholas Chiorazzi
Journal:  Blood       Date:  2010-01-28       Impact factor: 22.113

4.  Correlation between the amino acid position of arginine in VH-CDR3 and specificity for native DNA among autoimmune antibodies.

Authors:  M R Krishnan; N T Jou; T N Marion
Journal:  J Immunol       Date:  1996-09-15       Impact factor: 5.422

5.  Multilocus variable-number tandem-repeat analysis and multilocus sequence typing reveal genetic relationships among Clostridium difficile isolates genotyped by restriction endonuclease analysis.

Authors:  Jane W Marsh; Mary M O'Leary; Kathleen A Shutt; Susan P Sambol; Stuart Johnson; Dale N Gerding; Lee H Harrison
Journal:  J Clin Microbiol       Date:  2009-12-02       Impact factor: 5.948

6.  Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis.

Authors:  Fiona Murray; Nikos Darzentas; Anastasia Hadzidimitriou; Gerard Tobin; Myriam Boudjogra; Cristina Scielzo; Nikolaos Laoutaris; Karin Karlsson; Fanny Baran-Marzsak; Athanasios Tsaftaris; Carol Moreno; Achilles Anagnostopoulos; Federico Caligaris-Cappio; Dominique Vaur; Christos Ouzounis; Chrysoula Belessi; Paolo Ghia; Fred Davi; Richard Rosenquist; Kostas Stamatopoulos
Journal:  Blood       Date:  2007-10-24       Impact factor: 22.113

7.  Pathogenic autoantibodies in systemic lupus erythematosus are derived from both self-reactive and non-self-reactive B cells.

Authors:  Jie Zhang; Annett M Jacobi; Tao Wang; Betty Diamond
Journal:  Mol Med       Date:  2008-07-30       Impact factor: 6.354

8.  Extensive intraclonal diversification in a subgroup of chronic lymphocytic leukemia patients with stereotyped IGHV4-34 receptors: implications for ongoing interactions with antigen.

Authors:  Lesley-Ann Sutton; Efterpi Kostareli; Anastasia Hadzidimitriou; Nikos Darzentas; Athanasios Tsaftaris; Achilles Anagnostopoulos; Richard Rosenquist; Kostas Stamatopoulos
Journal:  Blood       Date:  2009-08-27       Impact factor: 22.113

9.  Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.

Authors:  Michael Hallek; Bruce D Cheson; Daniel Catovsky; Federico Caligaris-Cappio; Guillaume Dighiero; Hartmut Döhner; Peter Hillmen; Michael J Keating; Emili Montserrat; Kanti R Rai; Thomas J Kipps
Journal:  Blood       Date:  2008-01-23       Impact factor: 22.113

10.  Arginine mutation alters binding of a human monoclonal antibody to antigens linked to systemic lupus erythematosus and the antiphospholipid syndrome.

Authors:  Anastasia Lambrianides; Ian Giles; Yiannis Ioannou; Lesley Mason; David S Latchman; Jessica J Manson; David A Isenberg; Anisur Rahman
Journal:  Arthritis Rheum       Date:  2007-07
View more
  3 in total

Review 1.  Antigen receptor stereotypy in chronic lymphocytic leukemia.

Authors:  K Stamatopoulos; A Agathangelidis; R Rosenquist; P Ghia
Journal:  Leukemia       Date:  2016-11-04       Impact factor: 11.528

2.  Somatic hypermutation profiles in stereotyped IGHV4-34 receptors from South American chronic lymphocytic leukemia patients.

Authors:  Carmen Stanganelli; Davi Coe Torres; Claudia Ortega; María Elena Márquez; Victoria Remedi; Juana Cabrera; Claudia Mardaraz; Camila Galvano; Andrea Krzywinski; Cecilia Lang; Lorena Zanella; Evangelina Agriello; Raimundo Bezares; Astrid Pavlovsky; Miguel A Pavlovsky; Pablo Oppezzo; Irma Slavutsky
Journal:  Ann Hematol       Date:  2021-10-28       Impact factor: 4.030

Review 3.  Next-generation sequencing in chronic lymphocytic leukemia: recent findings and new horizons.

Authors:  Ana E Rodríguez-Vicente; Vasilis Bikos; María Hernández-Sánchez; Jitka Malcikova; Jesús-María Hernández-Rivas; Sarka Pospisilova
Journal:  Oncotarget       Date:  2017-07-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.